Early metabolic response of breast cancer to neoadjuvant endocrine therapy: comparison to morphological and pathological response

BACKGROUND: Neoadjuvant endocrine therapy (NET) has shown efficacy in terms of clinical response and surgical outcome in postmenopausal patients with estrogen receptor-positive / HER2-negative breast cancer (ER+/HER2- BC) but monitoring of tumor response is challenging. The aim of the present study...

Descripción completa

Detalles Bibliográficos
Autores principales: Boughdad, Sarah, Champion, Laurence, Becette, Veronique, Cherel, Pascal, Fourme, Emmanuelle, Lemonnier, Jerome, Lerebours, Florence, Alberini, Jean-Louis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6986018/
https://www.ncbi.nlm.nih.gov/pubmed/31992361
http://dx.doi.org/10.1186/s40644-020-0287-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6986018/
https://www.ncbi.nlm.nih.gov/pubmed/31992361
http://dx.doi.org/10.1186/s40644-020-0287-4

Ejemplares similares